palmitoylethanolamide.com.au
Home › Research › Rusbridge 2024

Neuropathic pain in cats: Mechanisms and multimodal management

Rusbridge C. J Feline Med Surg. 2024;26(5):1098612X241246518.

ReviewCats

Design
Review
Subjects
Narrative review with three case vignettes
Dose used in the study
Not applicable
Duration
Not applicable
What was measured
Mechanisms of neuropathic pain in cats and a treatment algorithm for general practitioners; the abstract mentions adjuvant drugs but does not name palmitoylethanolamide

What the authors reported

This presents a structured approach to recognising and managing neuropathic pain in cats, drawing on the literature and the author's own experience. The abstract lists analgesic, anti-inflammatory and adjuvant drugs and neuromodulation among the therapies, and includes three case vignettes and a treatment algorithm. It does not name palmitoylethanolamide or give any evidence for it.

Limits of this study

A clinical review by one author, not a trial or systematic review. The abstract says the evidence base is current literature where available plus the author's experience. It is not evidence of effect in cats. Author declares no conflicts.

Source

PubMed 38710218 · doi:10.1177/1098612X241246518

Entry checked against the abstract on PubMed on 2026-10-19. The dose shown is the dose the researchers used. It is not a recommendation. How to read this page.